Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen- induced Toxic shock syndrome

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Tilahun, Ashenafi Y ^a   Holz, Marah ^a   Wu, Tsung Teh ^b   David, Chella S ^a   Rajagopalan, Govindarajan ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; CHEMOKINE; CYTOKINE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE STORM; GENE DISRUPTION; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; LETHALITY; LIVER; LUNG; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SMALL INTESTINE DISEASE; T LYMPHOCYTE; TOXIC SHOCK SYNDROME; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; ENTEROPATHY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; SEPTIC SHOCK; TRANSGENIC MOUSE;

BACTERIA (MICROORGANISMS); MUS; MUS MUSCULUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTIBODIES, NEUTRALIZING; CHEMOKINES; CYTOKINES; DISEASE PROGRESSION; ENTEROTOXINS; HLA-DR3 ANTIGEN; INTERFERON-GAMMA; INTESTINAL DISEASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SHOCK, SEPTIC; SUPERANTIGENS;

EID: 79751490586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016764     Document Type: Article

References (50)

1. Yok-Al Que, Moreill P (2009) Staphylococcus aureus (Including Staphylococcal Toxic Shock). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 9ed. Philadelphia: Churchill Livingstone, Elsevier.
2. Lappin E, Ferguson AJ (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9: 281-290.
3. Aldape MJ, Bryant AE, Stevens DL (2006) Clostridium sordellii Infection: Epidemiology, Clinical Findings, and Current Perspectives on Diagnosis and Treatment. Clinical Infectious Diseases 43: 1436-1446.
4. Murray RJ (2005) Recognition and management of Staphylococcus aureus toxin-mediated disease. Internal Medicine Journal 35: S106-S119.
5. Todd JK (1985) Staphylococcal Toxin Syndromes. Annual Review of Medicine 36: 337-347.
6. Chuang YY, Huang YC, Lin TY (2005) Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs 7: 11-25.
7. Proft T, Fraser JD (2003) Bacterial superantigens. Clin Exp Immunol 133: 299-306.
8. Li H, Llera A, Malchiodi EL, Mariuzza RA (1999) The structural basis of T cell activation by superantigens. Annu Rev Immunol 17: 435-466.
9. John Chandy C, Niermann M, Sharon B, Peterson Marnie L, Kranz David M, et al. (2009) Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and Hypersensitivity. Clinical Infectious Diseases 49: 1893-1896.
10. Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL (2008) Kawasaki disease: an overview. Curr Opin Infect Dis 21: 263-270.
11. Takahashi N, Nishida H, Kato H, Imanishi Ki, Sakata Y, et al. (1998) Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. The Lancet 351: 1614-1619.
12. Madsen JM (2001) Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 21: 593-605.
13. McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104.
14. Taylor PC, Feldmann M (2009) Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 5: 578-582.
15. Singh JA, Beg S Lopez-Olivo MA Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7: CD008331.
16. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, et al. (1992) T cellmediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175: 91-98.
17. Fisher CJ, Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334: 1697-1702.
18. Rajagopalan G, Sen M, Singh M, Murali N, Nath KA, et al. (2006) Intranasal Exposure to Staphylococcal Enterotoxin B Elicits an Acute Systemic Inflammatory Response. Shock 25: 647-656.
19. Rajagopalan G, Tilahun AY, Asmann YW, David CS (2009) Early Gene Expression Changes Induced by the Bacterial Superantigen, Staphylococcal Enterotoxin B and its Modulation by a Proteasome Inhibitor. Physiol Genomics 90385.92008.
20. Tilahun AY, Theuer JE, Patel R, David CS, Rajagopalan G (2010) Detrimental Effect of the Proteasome Inhibitor, Bortezomib in Bacterial Superantigen- and Lipopolysaccharide-induced Systemic inflammation. Molecular Therapy In Press.
21. Faulkner L, Cooper A, Fantino C, Altmann DM, Sriskandan S (2005) The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J Immunol 175: 6870-6877.
22. DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, et al. (2002) Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis 185: 1754-1760.
23. Roy CJ, Warfield KL, Welcher BC, Gonzales RF, Larsen T, et al. (2005) Human Leukocyte Antigen-DQ8 Transgenic Mice: a Model To Examine the Toxicity of Aerosolized Staphylococcal Enterotoxin B. Infect Immun 73: 2452-2460.
24. Welcher BC, Carra JH, DaSilva L, Hanson J, David CS, et al. (2002) Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. J Infect Dis 186: 501-510.
25. Farrar MA, Schreiber RD (1993) The Molecular Cell Biology of Interferongamma and its Receptor. Annual Review of Immunology 11: 571-611.
26. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annual Review of Immunology 27: 485-517.
27. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, et al. (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140: 1506-1510.
28. Sheikh SZ, Matsuoka K, Kobayashi T, Li F, Rubinas T, et al. (2010) Cutting Edge: IFN-{gamma} Is a Negative Regulator of IL-23 in Murine Macrophages and Experimental Colitis. J Immunol 184: 4069-4073.
29. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-Î3 receptors. Journal of Immunology 158: 5501-5506.
30. Heinzel FP (1990) The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 145: 2920-2924.
31. Dinges MM, Schlievert PM (2001) Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice. Infect Immun 69: 1256-1264.
32. Wang Q, Fang CH, Hasselgren P-O (2001) Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281: R1013-1023.
33. Kishimoto H, Surh CD, Sprent J (1998) A role for Fas in negative selection of thymocytes in vivo. J Exp Med 187: 1427-1438.
34. Lavoie PM, Thibodeau J, Erard F, Sekaly RP (1999) Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol Rev 168: 257-269.
35. Miethke T, Duschek K, Wahl C, Heeg K, Wagner H (1993) Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol 23: 1494-1500.
36. Fraser DJ, Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunological Reviews 225: 226-243.
37. Rajagopalan G, Sen M, David CS (2004) In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonisits. Infect Immun 72: 6733-6737.
38. Rajagopalan G, Singh M, Sen MM, Murali NS, Nath KA, et al. (2005) Endogenous superantigens shape response to exogenous superantigens. Clin Diagn Lab Immunol 12: 1119-1122.
39. Rajagopalan G, Smart MK, Patel R, David CS (2006) Acute Systemic Immune Activation following Conjunctival Exposure to Staphylococcal Enterotoxin B. Infect Immun 74: 6016-6019.
40. Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, et al. (2006) Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 74: 1284-1296.
41. Rajagopalan G, Smart MK, Cheng S, Krco CJ, Johnson KL, et al. (2003) Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M. Tissue Antigens 62: 149-161.
42. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
43. Refaeli Y, Van Parijs L, Alexander SI, Abbas AK (2002) Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 196: 999-1005.
44. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Séris M, Vassalli P (1998) Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-c, TNF) in the induction of epithelial cell death and renewal. European Journal of Immunology 28: 730-744.
45. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, et al. (2003) Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis- Independent Mechanisms. J Immunol 171: 6164-6172.
46. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, et al. (2006) Interferongamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 146: 330-338.
47. Nava P, Koch S, Laukoetter MG, Lee WY, Kolegraff K, et al. (2010) Interferon- [gamma] Regulates Intestinal Epithelial Homeostasis through Converging [beta]-Catenin Signaling Pathways. Immunity 32: 392-402.
48. Madara JL, Stafford J (1989) Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83: 724-727.
49. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, et al. (2005) Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19: 923-933.
50. Silverstein R (2004) D-galactosamine lethality model: scope and limitations. J Endotoxin Res 10: 147-162.